AlphAIalphai — Financial news for AI agents
SEC EDGARJUN 302 min read$IRON

Khara Rahul sold $188K of IRON

Khara Rahul (Chief Legal Officer) sold 2,500 shares of Disc Medicine, Inc. (IRON) at $75.00 ($0.19M total) across 2 trades over 2026-06-26 to 2026-06-29 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Khara Rahul
Published Jun 30, 2026, 9:49 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 30, 2026, 9:52 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$IRON
Neutral
high confidence
Mentioned
$IRON
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$IRONNeutralLow
01

Why it matters

The disclosure updates the insider trading record with exact sale dates, share count, and total value, but does not introduce new operational, clinical, or financial information.

02

Market read

Traders may monitor for follow-on insider activity, but the 10b5-1 framing typically reduces immediate price impact expectations.

03

What to watch

The filing confirms execution price ($75) and remaining holdings (52,173 shares), but does not indicate whether future tranches will accelerate or whether there are concurrent buys/sales by other insiders.

Relevance 3/10Novelty 5/10Timing: SEC Form 4 filed 2026-06-30 (after-hours) disclosing sales from 2026-06-26 to 2026-06-29

Background

The article is an SEC Form 4 insider transaction disclosure for Disc Medicine, Inc. (IRON).

Company-level read

Ticker impact

$IRONNeutralHigh confidence
Context

Disc Medicine insider Khara Rahul (Chief Legal Officer) sold $187,500 of IRON stock via a Rule 10b5-1 plan at $75/share (Form 4).

Expected impact

Likely minimal near-term impact; any effect would be sentiment-only rather than fundamental.

Evidence & confidence

The filing is a Form 4 insider transaction with stated pre-arranged 10b5-1 plan; it discloses sale size, dates, and $75/share execution without any new company fundamentals.

Market effects

Sector

No sector read-through; this is company-specific insider liquidity disclosure.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

Because the sale is pre-arranged under 10b5-1, it may be less informative than discretionary selling; traders may ignore it unless paired with other negative catalysts.

Key entities

  • public_company
    IRON

    Disc Medicine, Inc.; subject of the Form 4 insider sale disclosure.

  • insider
    Khara Rahul

    Chief Legal Officer who sold 2,500 shares at $75/share under a Rule 10b5-1 plan.

Read at source← All news

Related articles

JUL 30
$IRONMed

Disc Medicine, Inc. (IRON): Results of Operations and Financial Condition

Disc Medicine, Inc. (IRON) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 iron-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Disc Medicine Reports Second Quarter 2026 Financial Results and Provides Business Update • Completed Type A meeting with the FDA on bitopertin and aligned that the Phase 3 APOLLO study, if successful, can serve as the basis f

SEC EDGAR 8-K5 min
JUL 17
$NEEMed

SMALL-CAP MOVERS: Britain's bargain basement and the overseas buyers who can't believe their luck

The article reports AIM takeover activity: Gooch & Housego PLC is being acquired in a £346m deal, and Ramsdens Holdings PLC is set to be bought for £230m. It also notes NextEnergy Solar rose 10% after putting itself up for sale, and highlights large AIM share moves for Ironveld, Itaconix, Jersey Oil and Gas, Safestay, Galileo Resources, and Iofina. Iofina reported 393.3 tonnes H1 2026 and raised guidance to 460-485 tonnes.

proactiveinvestors.co.uk7 min
JUL 14
$IRONMed

Ironveld shares jump 32% at 0.025p as processing plant hits sustained production

Ironveld PLC (AIM:IRON) shares rose 32% to 0.025p after the company said its dense media separation plant reached sustained production. It now runs 16 hours daily on double shift, processing 2.5-3.5 tonnes per hour and producing 1.4 tonnes/hour in-spec magnetite plus about 1 tonne/hour maghemite. Three clients secured, with a 5,000 tonnes/month buyer sampling; expansion options and Mintek study ongoing.

proactiveinvestors.co.uk3 min
JUN 12
$IRONMed

Disc Medicine Presents Positive Clinical Updates at the 2026 European Hematology Association (EHA) Annual Meeting

Disc Medicine (NASDAQ:IRON) reported updated clinical data at the 2026 EHA meeting in Stockholm. In RALLY-MF, DISC-0974 showed durable overall anemia responses in myelofibrosis across subgroups, including 55% major hemoglobin response in non-transfusion dependent patients and transfusion independence in 64% (TD Low) and 50% (TD High). In HELIOS, bitopertin sustained PPIX reductions and improved light tolerance with favorable longer-term safety. A corporate call is set for June 15.

manilatimes.net4 min
JUN 4
$IRONLow

Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON

Rosen Law Firm said it is investigating potential securities claims for Disc Medicine, Inc. (NASDAQ: IRON) shareholders, alleging materially misleading business information. The firm cited an FDA Complete Response Letter on Feb. 13, 2026 for Disc Medicine’s bitopertin NDA, citing uncertainties needing more evidence; IRON shares fell 22% that day.

prnewswire.com2 min
JUN 4
$IRONLow

Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON

Rosen Law Firm said it is investigating potential securities claims for Disc Medicine, Inc. (NASDAQ: IRON) investors over allegations of materially misleading business information. The firm cited an FDA Complete Response Letter on Feb. 13, 2026 for Disc Medicine’s bitopertin NDA, citing uncertainties needing more evidence; IRON shares fell 22% that day.

prnewswire.com2 min